Related Experiment Videos
Phenytoin elimination in childhood: effect of concentration-dependent kinetics
Insights
Phenytoin (PHT) concentration significantly impacts its elimination rate in young individuals. Higher PHT levels lead to a longer effective half-life, suggesting adjusted dosing strategies may be beneficial.
Area of Science:
- Pharmacokinetics
- Pediatric Pharmacology
- Drug Metabolism
Background:
- Phenytoin (PHT) is a widely used antiepileptic drug.
- Understanding PHT elimination is crucial for optimizing therapeutic outcomes, especially in pediatric populations.
- Previous studies on PHT half-life in children have yielded varied results, necessitating further investigation into concentration-dependent effects.
Purpose of the Study:
- To evaluate the relationship between phenytoin (PHT) concentration and its elimination rate in individuals from infancy to young adulthood.
- To determine how PHT concentration influences its effective half-life (t50%) across different age groups.
- To inform potential adjustments in PHT dosing regimens based on concentration-dependent elimination.
Main Methods:
- Pharmacokinetic analysis of PHT concentrations and elimination rates in a cohort aged 1 day to 22 years.
- Measurement of effective half-life (t50%) at varying PHT concentrations.
- Comparison of t50% values between pediatric subgroups and adults with similar PHT concentrations.
Main Results:
- A positive correlation was observed between increasing PHT concentration and an increased effective half-life (t50%).
- In children aged 7 months to 4.83 years, the average t50% at concentrations of 10-20 mg/L was approximately 58% longer than in adults at comparable concentrations.
- No significant correlation was found between t50% and patient age, body size, or the number of concomitant antiepileptic drugs.
Conclusions:
- Phenytoin elimination exhibits concentration-dependent kinetics in pediatric and young adult populations.
- The increased effective half-life at higher PHT concentrations supports less frequent dosing than predicted by studies with low concentrations.
- These findings have implications for refining PHT dosing strategies in children to improve therapeutic management.
Abstract:
The effect of phenytoin (PHT) concentration on the elimination rate of PHT was evaluated in infants, children, and young adults ranging in age from 1 day to 22 years. As PHT concentration increased, the effective half-life (t50%) increased. In eight children, age 7 months to 4.83 years with initial concentrations between 10 to 20 mg per liter, the average t50% (18.6 hours) was approximately 58% as long as the average in adults with comparable concentrations. Whereas the t50% correlated with the initial PHT concentrations, there was no correlation overall between t50% and age, size, or number of other antiepileptic medications taken. The concentration-dependence of the t50% provided the basis for less frequent dosing than one would expect from previous studies of PHT half-life in children with low concentrations.